Monday, June 24

New guidelines imply 3.6 million People may get Wegovy through Medicare, co…



New rules mean 3.6 million americans could get wegovy via medicare, costing billions

A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF analysis says.

That’s because the U.S. Food and Drug Administration has approved the use of Wegovy (semaglutide) to reduce the risk of heart attacks and stroke in certain patients, the study says.

The FDA’s ruling potentially allows Wegovy prescription coverage for more than a quarter of 13.7 million Medicare patients who’ve been diagnosed with obesity or excess weight, KFF says.

Those 3.6 million people—about 7% of all beneficiaries—have established heart disease as well as excess weight, and thus could be eligible for coverage of…


Leave a reply